ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0357

Identifying Predictors of Unemployment in Axial Spondyloarthropathy: Data from the Ankylosing Spondylitis Registry of Ireland

Sinead Maguire1, Wilson Fiona2, Phil Gallagher3 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2Discipline of Physiotherapy, Trinity College Dublin, Dublin, Ireland, 3St Vincent's Hospital, Dublin, Ireland

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), Economics, Employment, Spondylarthropathies, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Axial spondyloarthropathy (axSpA) is an inflammatory arthritis of the axial skeleton. Persistent disease activity can result in significant disability and affect ability to maintain employment. The Ankylosing Spondylitis Registry of Ireland (ASRI) is a source of epidemiological data on axSpA in Ireland. The aim of this study was to examine the prevalence of unemployment in axSpA and quantify the impact on burden of disease, level of function and quality of life.

Methods: For the purposes of this analysis data was extracted from the ASRI on participants with employment data recorded. Patients were analysed on the basis of employment and categorised as employed or unemployed. A two tailed t-test was used to test for statistical significance in mean continuous variables between groups. For categorical variables, an independent chi-squared test of independence determined statistical significance. An alpha level of p< 0.05 was deemed significant. IBM SPSS v.26 was used for data and statistical analysis.

Results: Employment status was available for 876 patients enrolled in the ASRI. Overall 21.6% (189) of the population was unemployed, which is considerably higher than national averages of 6.2-13.1% during the same period. In addition, 24% (213) reported axSpA as a limitation in work ability. Unemployed patients reported significantly worse BASDAI (5.2 vs 3.7, p< 0.01), BASMI (4.8 vs 3.79, p< 0.01), BASFI (5.24 vs 3.26, p< 0.01), HAQ (0.83 vs 0.45, p< 0.01), and ASQoL scores (9.61 vs 5.63, p< 0.01) compared to employed axSpA patients(figure 1). A higher proportion of males were unemployed as compared to females (table 1). No significant differences were noted in pattern of disease, medication usage or baseline demographics. Male sex (OR 2.31, 95% CI 1.32-4.04), worse BASMI (OR 1.19, 95% CI 1.05-1.35) and worse ASQoL scores (OR 1.07, 95% CI 1.01-1.14) were found to be significant predictors of unemployment (table 2).

Conclusion: Prevalence of unemployment in axSpA is notably higher than nationally reported averages from the general population. Despite a high uptake of biologic therapy in this group, these patients have higher levels of disease activity, poorer levels of function and worse quality of life compared to employed axSpA patients. Predictors of unemployment were male sex, worse spinal mobility and poorer quality of life. In males, higher average BASMI scores were a significant contributing factor to the higher rates of unemployment observed. Prompt intervention for patients with worsening outcome measures, in particular spinal restriction, would provide an opportunity for occupational supports and prevent progression to unemployment.

Table 1: Characteristics of the employed versus unemployed cohort in the ASRI

Figure 1: Comparison of mean outcomes on the basis of employment, all differences were statistically significant at the p<0.01 level

Table 2: Prediction model for risk of unemployment in AxSpA


Disclosures: S. Maguire, Gilead, 5; W. Fiona, None; P. Gallagher, None; F. O'Shea, None.

To cite this abstract in AMA style:

Maguire S, Fiona W, Gallagher P, O'Shea F. Identifying Predictors of Unemployment in Axial Spondyloarthropathy: Data from the Ankylosing Spondylitis Registry of Ireland [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/identifying-predictors-of-unemployment-in-axial-spondyloarthropathy-data-from-the-ankylosing-spondylitis-registry-of-ireland/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-predictors-of-unemployment-in-axial-spondyloarthropathy-data-from-the-ankylosing-spondylitis-registry-of-ireland/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology